symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ACST,2.61,1.328378,51534,24532434,0,1.72-5.04,-0.01,Acasti Pharma Inc.,USD,0001444192,CA00430K4028,00430K402,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.acastipharma.com,"Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.",Mr. Prashant  Kohli,Healthcare,CA,32,450 687 2262,3009 boulevard de la Concorde East,Laval,QC,H7E 2B5,3.43547,4.46547,https://financialmodelingprep.com/image-stock/ACST.png,2012-02-07,False,False,True,False,False
